The Valley Desk

NCT00586651 · Interventional trial

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Overall registry status Completed

Phase 2

Conditions Essential Thrombocytosis, Polycythemia Vera

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov